ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

ANGPTL8 is a negative regulator in pathological cardiac hypertrophy

Abstract Pathological cardiac hypertrophy is an independent risk factor for heart failure and is considered a target for the treatment of heart failure. However, the mechanisms underlying pathological cardiac hypertrophy remain largely unknown. We aimed to investigate the role of angiopoietin-like p...

Full description

Bibliographic Details
Main Authors: Lin Hu, Jiarui Wei, Yue Zhang, Ziyuan Wang, Junming Tang, Jian Tang, Yujiu Gao, Xiaoqiao Zhang, Yifan Li, Yantong Liu, Shinan Ma, Xingrong Guo, Qiufang Zhang
Format: Article
Language:English
Published: Nature Publishing Group 2022-07-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-05029-8

Internet

https://doi.org/10.1038/s41419-022-05029-8

Similar Items